Recent Regulatory Developments

December 20, 2019
Final List of High-Priority Chemicals Will Be Next to Undergo Risk Evaluation under TSCA
December 20, 2019
EPA Releases Updated Version of “Working Approach” Document for New Chemicals Review
December 18, 2019
EC Begins Public Consultations on Fitness Check of EU Legislation Regarding Endocrine Disruptors
December 13, 2019
FAQs Regarding Brexit—What Chemical Companies Need To Know
December 9, 2019
Requirements for South Korean Manufacturers and Importers of Chemicals Continue to Change
December 5, 2019
EPA Seeks Information on PFAS for Possible Addition to TRI List of Toxic Chemicals
December 3, 2019
Less Than One Month until California Online Ingredients Disclosure Requirements in Effect for Designated Cleaning Products
November 14, 2019
House Committee Holds Hearing on the Future of Science in EPA Rulemaking
November 5, 2019
EPA Releases Draft Risk Evaluation for NMP, Schedules SACC Review for December
October 31, 2019
EPA Publishes Draft Risk Evaluation for Methylene Chloride
 < 1 2 3 4 >  Last › View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2020 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.